Trial Outcomes & Findings for Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease (NCT NCT00601146)

NCT ID: NCT00601146

Last Updated: 2020-01-21

Results Overview

In this study, patients will under annual low-dose chest CT screening. The total number of lung cancer detected through the screening will be recorded

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 39 participants
• Primary outcome timeframe: 3 years
• Results posted on: 2020-01-21

Participant Flow

Participant milestones

Measure	Low-dose CT Screening Annual low-dose chest CT screening
Overall Study STARTED	39
Overall Study COMPLETED	39
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Baseline characteristics by cohort

Measure	Low-dose CT Screening n=39 Participants Annual low-dose chest CT screening
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	37 Participants n=5 Participants
Age, Categorical >=65 years	2 Participants n=5 Participants
Age, Continuous	51 years n=5 Participants
Sex: Female, Male Female	16 Participants n=5 Participants
Sex: Female, Male Male	23 Participants n=5 Participants
Region of Enrollment United States	39 participants n=5 Participants

PRIMARY outcome

Timeframe: 3 years

Population: Enrolled patients who underwent low-dose CCT screening- number of lung cancer diagnosed

In this study, patients will under annual low-dose chest CT screening. The total number of lung cancer detected through the screening will be recorded

Outcome measures

Measure	Low-dose CT Screening n=36 Participants Annual low-dose chest CT screening
To Prospectively Collect Data on Chest CT Screening for Patients at Increase Lung-cancer Risk After Hodgkin's Disease.	0 participants

Adverse Events

Low-dose CT Screening

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Andrea Ng

DFCI

Phone: 617-732-6310

Email: ang@lroc.harvard.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place